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Abstract
Motivation: Molecular pathways and networks play a key role in basic and disease biology. An
emerging notion is that networks encoding patterns of molecular interplay may themselves differ
between contexts, such as cell type, tissue or disease (sub)type. However, while statistical testing
of differences in mean expression levels has been extensively studied, testing of network differ-
ences remains challenging. Furthermore, since network differences could provide important and
biologically interpretable information to identify molecular subgroups, there is a need to consider
the unsupervised task of learning subgroups and networks that define them. This is a nontrivial
clustering problem, with neither subgroups nor subgroup-specific networks known at the outset.
Results:We leverage recent ideas from high-dimensional statistics for testing and clustering in the
network biology setting. The methods we describe can be applied directly to most continuous mo-
lecular measurements and networks do not need to be specified beforehand. We illustrate the
ideas and methods in a case study using protein data from The Cancer Genome Atlas (TCGA). This
provides evidence that patterns of interplay between signalling proteins differ significantly be-
tween cancer types. Furthermore, we show how the proposed approaches can be used to learn
subtypes and the molecular networks that define them.
Availability and implementation: As the Bioconductor package nethet.
Contact: staedler.n@gmail.com or sach.mukherjee@dzne.de
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Molecular interplay plays a fundamental role in biology and its dys-
regulation is a feature of many diseases. It is thought that networks
encoding molecular interplay may depend on biological context
such as cell type, tissue type, or disease subtype. An increasing
number of studies, including, among others, ENCODE (Andersson
et al., 2014), BLUEPRINT (Martens and Stunnenberg, 2013) and
TCGA (The Cancer Genome Atlas Network, 2012), span multiple
biological contexts and such studies offer an opportunity to better
understand molecular heterogeneity.
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The study of molecular networks involves relatively complex
statistical models, since it is not only the mean levels of molecular
variables but also measures of interplay between them that are rele-
vant. For this reason, despite the importance of networks in biology,
several core bioinformatics tasks remain challenging in the network
setting. In this paper we address two of these, two-sample testing
and clustering. In network models, the number of statistical param-
eters may grow rapidly with the number of molecular variables and
for this reason network-based analyses typically lead to so-called
high-dimensional statistical problems, where the number of param-
eters is large in relation to the sample size.
To fix ideas and clarify the specific questions we address, first con-
sider molecular data X1;X2 from two groups, each with the same set
of variables measured, but with potentially different sample sizes.
Using these data, we would like to test significance of differences be-
tween the groups, not only in terms of average molecular abundance
(as tested in standard differential expression analyses and multiple
testing extensions thereof), but at the level of networks describing
interplay between the variables. In the general case group-specific net-
works are not known in advance but must be estimated from the data
and the resulting variability in estimation must be properly accounted
for. This is the testing problem that we address.
Next consider the unknown groups case, where starting with a
dataset X (with no group labels) we seek to identify subsets of sam-
ples (i.e. clusters) with their associated networks. In general neither
the cluster assignments nor cluster-specific networks are known at
the outset. This is the clustering problem that we address.
The testing and clustering problems are different, but share the
need to model underlying networks. We use sparse Gaussian graph-
ical models (GGMs) for this purpose. The approaches we discuss are
likelihood-based and should be extensible to other classes of model.
Estimation for GGMs has been widely studied, including in bioinfor-
matics (e.g. Sch€afer and Strimmer, 2005). There has been progress in
high-dimensional methods relevant to testing and clustering using
GGMs (including Chen and Qin, 2010; St€adler and Mukherjee, 2013,
2017; Zhou et al., 2009). We note that GGMs are not causal models
and we do not consider causality per se in this paper, although exten-
sions in a causal direction could be possible.
We address the testing problem using a framework proposed in
St€adler and Mukherjee (2017) that extends the likelihood ratio test to
the high-dimensional setting. Specifically, we use an application of
their methodology to testing networks called Differential Network or
DiffNet. This is a formal statistical test that retains validity in the
high-dimensional setting. For a review of related methods and a dis-
cussion of methodological differences with respect to the DiffNet test,
we refer the interested reader to the reference.
For the clustering problem, we pursue a model-based approach. In
particular, we use mixture models where the different mixture compo-
nents (or clusters) are represented by cluster-specific means and
GGMs. Gaussian mixture models have been well-studied in the low-
dimensional setting but estimation remains challenging in the high-
dimensional setting. In the present context, we are interested in inter-
play between molecular variables and furthermore we expect that
clusters may have different underlying GGMs. This requires formula-
tions for which classical maximum likelihood is ill-suited (even when
the number of molecular variables p itself is not very large). A compu-
tationally and statistically attractive approach is to use ‘1-penalization
within a mixture model framework and this is the route we pursue.
Specifically, we develop a latent variable extension of the graphical
lasso (Friedman et al., 2008) that we call Mixture Graphical Lasso, or
MixGlasso. MixGlasso renders estimation tractable by assuming
sparsity of the cluster-specific networks, i.e. for each cluster only
relatively few edges are important (but these edges are not pre-
specified and can differ between clusters).
The features of MixGlasso that make it practically applicable for
bioinformatics are: (i) MixGlasso allows clusters to have different
means and networks (i.e. GGMs). (ii) The penalty is designed to
automatically adapt to the number of clusters and to the sample size
and scale of the clusters (these are unknown at the outset and cannot
be dealt with by pre-processing). (iii) MixGlasso uses theoretical re-
sults from high-dimensional regression to set the level of penaliza-
tion automatically, following recent work in the context of hidden
Markov models (St€adler and Mukherjee, 2013). This means that the
procedure is essentially free of tuning parameters and efficient
enough to be run on a single core.
Many clustering methods that are widely used in bioinformatics,
including K-means, PAM and hierarchical clustering, differ funda-
mentally from MixGlasso in that they are driven by mean levels of
variables and do not account for network or covariance structure.
The mclust multivariate clustering tool (Fraley et al., 2012) is very
popular. The key difference between mclust and MixGlasso is that
the former is not geared towards high-dimensional problems.
Mukherjee and Hill (2011) discuss penalized, network-based clus-
tering, but using a heuristic algorithm that unlike MixGlasso is not a
principled mixture model. The iCluster methodology (Shen et al.,
2009) performs high-dimensional clustering via a low-dimensional
representation; this differs in intent from MixGlasso, which empha-
sizes the network setting in which the original molecular variables
and their network connections are of direct interest.
Pan and Shen (2007) used penalization for variable selection in clus-
tering, using a mixture model with common diagonal covariance matri-
ces. In contrast, MixGlasso focuses on the non-identical, non-diagonal
case that is relevant to discovery of clusters that may have different
underlying patterns of molecular interplay. Our approach is similar to
Zhou et al. (2009) but differs in the form of the penalty: the MixGlasso
penalty is designed to automatically adapt to the sample size and scale
of clusters and the level of penalization is set automatically.
In summary, the specific contributions of this paper are: (1) We
discuss how the DiffNet test can be used for network-related testing
in bioinformatics. (2) We propose a penalized mixture model
MixGlasso that can be used to cluster data that is likely to be hetero-
geneous with respect to underlying networks and that automatically
takes care of several practical issues; and (3) We illustrate the prop-
erties and use of the two approaches by way of simulations and a
TCGA case study.
We illustrate the approaches in an analysis of protein data from
n ¼ 3467 TCGA samples (data from Akbani et al., 2014). Using
DiffNet we show that patterns of protein-protein interplay differ sig-
nificantly between cancer types, both at the ‘global’ level of all assayed
proteins and at the ‘local’ level of pre-defined signaling pathways. This
offers evidence, over thousands of samples, supporting the notion that
signaling depends on disease lineage and context, i.e. that pathways
and networks are contextual. Furthermore, using MixGlasso, we iden-
tify clusters (that can span more than one cancer type or classical lin-
eage) each having a cluster-specific network. This analysis supports,
from a network perspective, the emerging notion that there may be
molecular commonalities between seemingly distinct cancer types (see
e.g. The Cancer Genome Atlas Network, 2012).
2 Materials and methods
We first introduce some notation. Let the number of samples be n,
the number of variables be p and the np data matrix be
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X ¼ X1 . . .Xn½ T. Data subsets or groups are indexed by
k 2 f1; . . . ;Kg. For each group k, nk denotes the (group-specific) sample
size and Xk is the corresponding nk  p data matrix. Group-specific
mean vectors and inverse covariance matrices are lk andXk respectively.
2.1 DiffNet: testing differences in patterns of molecular
interplay
To test whether known groups differ with respect to molecular net-
works, a starting point is to learn a network model for each group
and to then compare the models. Although many procedures are
available for learning networks (see e.g. De Smet and Marchal,
2010), the models are inherently complex and typically subject to
high statistical variability. This means that observed differences be-
tween fitted models may simply be due to such variability. This mo-
tivates a need for uncertainty quantification.
The DiffNet test that we use is based on a framework that ex-
tends the likelihood ratio test (LRT) to high-dimensions (St€adler and
Mukherjee, 2017). DiffNet assumes that the data are generated
from GGMs and tests the null hypothesis that both groups share the
same underlying model, i.e. the null hypotheses
H
k;k0ð Þ
0 : Xk ¼ Xk0 ; k;k0 2 f1; . . . ;Kg and k 6¼ k0: (2.1)
The key idea in DiffNet is to exploit estimated sparsity patterns in
the construction of the test statistic and in P-value calculation. The
use of sparse structure renders the test effective in high-dimensions
but raises technical questions that are addressed via theory that ex-
tends the LRT to the high-dimensional setting. This gives an asymp-
totic P-value that remains valid in high-dimensional problems.
DiffNet uses randomized data-splitting: sparsity structure is esti-
mated using the first half of the data, and P-value calculation carried
out using the second half. We consider two variants of DiffNet, one
using a single data split (‘DiffNet(SS)’) and one using multiple
data splits (50 data splits) followed by P-value aggregation
(‘DiffNet(MS)’). For full technical details we refer the interested
reader to St€adler and Mukherjee (2017). The overall analysis is com-
putationally tractable: on the TCGA protein data discussed below a
typical (single-split) run of DiffNet required 2.5 minutes and 2.5 GB
of memory (on one core of an Intel Nehalem processor).
2.2 Subtype identification using MixGlasso
MixGlasso is a penalized mixture of Gaussian graphical models. As
above, let k index groups and K denote the number of groups (in the
clustering setting both K and cluster assignments are unknown at
the outset). Let Si 2 f1; . . . ;Kg be latent labels with Si ¼ k if sample
i belongs to group k. The component probabilities (i.e. mixture
weights) are pk ¼ P Si ¼ kð Þ. We assume XijSi ¼ k  N lk;X1k
 
,
where N l;Rð Þ denotes a normal density with mean l and covariance
matrix R. The mixture model is then parameterized by
HK ¼ h1; . . . ; hK;p1; . . . ; pKð Þ; hk ¼ lk;Xkð Þ, with log-likelihood
‘ HK;Xð Þ ¼
X
i
log
X
k
pk N Xijlk;X1k
  !
: (2.2)
Estimation comprises two (coupled) tasks. The first task is to esti-
mate HK, given the number of clusters K. In MixGlasso this is done
by minimizing the negative penalized log-likelihood to get
bHK;k ¼ arg min
HK
‘ HK;Xð Þ þ k pen HKð Þ; (2.3)
where
pen HKð Þ ¼
XK
k¼1
p1=2k
X
j6¼j0
jXk;jj0 j=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Xk;jjXk;j0 j0
q
is the penalty function and k is a regularization parameter. This
specific form of penalty, originally introduced in St€adler and
Mukherjee (2013) for hidden Markov models, adapts to the sample
size and scale of individual clusters. Optimization of (2.3) is per-
formed using expectation-maximization (EM) as outlined in SI.
We set k to a ‘universal’ value kuni ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
2n logp
p
=2. This penalty
is based on well-known theoretical results for high-dimensional re-
gression and the connection between GGMs and regression, and in
the present setting is valid for the specific penalty given above (for
details see St€adler and Mukherjee, 2013). The use of kuni coupled
with the penalty above in effect allows automatic adaptation to clus-
ter size and scale during the EM. As we show below, this allows
MixGlasso to give good results across a range of settings, while con-
trolling the computational burden; running MixGlasso on the
TCGA dataset (see below) with K ¼ 9 clusters required 2 minutes
and 5.3 GB of memory (on one core of an Intel Nehalem processor).
The second task involves determining an appropriate number
of clusters K. This is done by minimizing the BIC score (k is set to kuni):
K ¼ arg min
K
BIC bHK;kuni ;
with
BIC bHK;kuni  ¼ ‘ bHK;kuni ;X þ 12 log nð Þ K 1ð Þ
þ1
2
log nð Þ
XK
k¼1
Df k; kunið Þ;
where degrees of freedom are set as Df k; kunið Þ ¼ pþ
P
l0l 1 bXk;kuni ll0 6¼0 .
3 Results
3.1 Testing differences in patterns of molecular
interplay
Simulation study. Figure 1A presents results of a simulation study,
based on the characteristics of the TCGA data (including sample
size and dimensionality; see SI for details), that compares differential
network (‘DiffNet’) against standard multivariate tests. The meth-
ods we compare against are:
1. Likelihood ratio test (‘LRT (Asym)’). This is a classical LRT,
based on the Gaussian models and with an asymptotic P-value.
2. Permutation LRT (‘LRT(Perm)’). This uses the same test statistic
as the classical LRT, but obtains a P-value by permutation of
group labels.
3. Test based on Fisher’s Z-transform (‘Mult.FisherZ’). Here,
equality of all partial correlations is tested using P-values
obtained by transforming each partial correlation using Fisher’s
Z-transform (see SI Section 2.2).
In line with theoretical results, we find that DiffNet controls type I
error. Both DiffNet variants, but especially the multi-split variant,
outperform the other approaches in an ROC sense and in terms of
power. The permutation LRT is considerably less powerful than
DiffNet, but as expected catches up at larger sample sizes. The poor
performance of the classical LRT is expected (due to the high-
dimensional nature of the problem) and it is interesting to note that
LRT(Asym) does not control Type I error even with 50% more
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samples than available in TCGA (i.e. more than 300 samples per
group; with number of variables p¼181). Additional simulations
using a non-Gaussian model appear in Supplementary Figure S1A.
TCGA data. Next, we considered TCGA protein data (spanning
p ¼ 181 proteins listed in Supplementary Table S1) from Akbani
et al. (2014). Normalization for batch effects using control samples
is discussed in Akbani et al. (2014); here, we use the normalized
data presented there and refer the interested reader to the reference
for details.
Akbani et al. (2014) inferred networks specific to each of the 11
cancer types in the data using the graphical lasso (Friedman et al.,
2008). Without using biological prior knowledge, the networks cap-
tured many known links but also showed many differences between
cancer types. We used DiffNet to assess the significance of differ-
ences between cancer types (Fig. 1B). These results account for un-
certainty in network estimation and adjust for multiple comparisons
due to testing across cancer-type pairs. Some pairs of cancers do not
show significant network differences at the 1% FDR level, including
READ/COAD, LUAD/LUSC, LUSC/HNSC and UCEC/BLCA (the
first three pairs are known to be closely related). Our results show
that with these exceptions, most cancer types indeed appear to be
significantly different at the network level.
We also carried out a similar but ‘local’ analysis using only pro-
teins belonging to specific pre-defined pathways (listed in
Supplementary Table S2) rather than all proteins together as above.
This analysis can be thought of as similar to a gene-set test, but one
that captures differences in partial correlation patterns between gene
set members (see St€adler and Mukherjee, 2015). This broadly
confirmed the global view, but revealed a number of pathway-
specific insights (Supplementary Fig. S2).
3.2 Subtype identification using MixGlasso
Simulation study. We tested MixGlasso using a simulation strategy
that, as above, aimed to mimic the TCGA protein data. In brief this
was done by defining clusters corresponding to the cancer types in the
TCGA data, with cluster-specific parameters given by estimates from
the TCGA data. Data were then generated from the resulting model.
This allowed us to mimic some features of the real data (including sam-
ple size and dimensionality) while allowing access to ground-truth clus-
ter assignments. We compared MixGlasso to the following approaches:
• K-means clustering (‘K-means’).
• Hierarchical clustering (hclust).
• Conventional Gaussian mixture model (‘Gaussian Mixture’).
This is a classical Gaussian mixture model with unconstrained
covariance matrices, fitted using maximum likelihood.
• Gaussian mixture model with model selection (mclust). This is a
model-based approach due to Fraley et al. (2012) that is one of
the most widely used tools for mixture modelling.
• Penalized Gaussian mixture model (‘Gaussian Mixture (penal-
ised)’). This is a Gaussian mixture model with ‘1-penalized in-
verse covariance matrices. The penalty is as described in Zhou
et al. (2009), but without penalization of the means. The key dif-
ference to MixGlasso is that the penalty does not adapt to the
cluster-specific sample size and scale.
We first investigated the estimation of the number K of clusters.
There is a vast literature on this topic and a wide range of heuristics
used in practice. We are interested in addressing the high-
dimensional issues inherent to network-based clustering. For a
focused comparison, we therefore compared MixGlasso against
mclust and the penalized Gaussian mixture model as these methods
make similar modeling assumptions to MixGlasso but differ in how
they handle the high-dimensional aspect. This allows for a direct
comparison, using the same model selection approach to select the
number of clusters in each case. All the methods are likelihood-
based and we used the Bayesian Information Criterion or BIC to set
the number of clusters. The penalized Gaussian mixture model used
the same regularization parameter kuni as MixGlasso (see Section
2.2). Figure 2A shows the results of the analysis. MixGlasso comes
closest to determining the correct number of clusters (K¼9), and
also agrees well with true cluster assignments.
Next, we considered accuracy of cluster assignments as a func-
tion of sample size (Fig. 2B). We included K-means and hclust in the
comparison. To avoid confounding by choice of model selection
heuristic, we treated the true number of clusters as known and
focused on comparing cluster assignments. As expected, perform-
ance improves with sample size; however, at smaller sample sizes,
MixGlasso tends to outperform the other methods, and only at large
sample sizes do the classical mixture models catch up.
Several of the methods, including MixGlasso, make Gaussianity
assumptions. We therefore performed additional simulations using a
non-Gaussian model (Supplementary Fig. S1B, see also SI Section 4);
MixGlasso appears reasonably robust to departures from Gaussianity.
TCGA data. First we used BIC to select the number of clusters K;
this showed an optimum at K ¼ 8 (Fig. 3A). We tested stability by it-
erative subsampling; at each iteration, we removed 1/4 of the data
samples at random, and then scored between-iteration concordance
between assignments (using the adjusted Rand index). MixGlasso is
highly stable with an adjusted Rand index of 0.9460.03 over
Fig. 1. (A) Differential network (DiffNet), simulation study. Left-to-right (all as
a function of sample size): Type-I error (false positive rate); power (true posi-
tive rate); and area under the ROC curve. Average performance over 100
simulation runs shown. The simulation was designed to mimic characteristics
and sample size of the TCGA protein data for LUAD and GBM (see SI for
details). X-axis shows the smaller of the sample sizes of the two compared
groups and the multiplier with respect to the TCGA sample sizes.
[‘LRT(Asym)’: asymptotic likelihood ratio test (LRT); ‘LRT(Perm)’: permuta-
tion-based LRT; ‘Mult.FisherZ’: Fisher’s Z Transform; ‘DiffNet(SS)’: single-split
DiffNet; ‘DiffNet(MS)’: multi-split DiffNet (see text)]. (B) DiffNet results, TCGA
protein data. Heatmap shows FDR-corrected P-values indicating significance
of differences between 11 cancer types, using data for 181 proteins, including
post-translational modifications (see Methods). To focus on network-related
differences rather than differential expression, data from each cancer type
were normalized to have zero mean and unit variance as a pre-processing
step. [ns indicates non-significant cancer pairs with FDR> 1%]
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subsamples. To assess the stability of individual clusters we addition-
ally used a resampling approach due to Hennig (2007) that quantifies
individual cluster quality (Supplementary Fig. S3A).
Most of the clusters show a dominant cancer or lineage member-
ship; accordingly we named the clusters after the dominant can-
cer(s). An exception is a cluster that spans 10/11 cancers and has no
dominant cancer; we named this cluster ‘M’ (for mixed) and discuss
it below. Figure 3C shows networks across all clusters, indicating
cluster-specific as well as shared edges. Note that the partial correl-
ations shown here are obtained by first estimating the cluster mem-
bership using MixGlasso, then merging proteins whose expression
profiles are highly correlated with those of their phosphorylated
forms, and finally re-estimating the networks using the graphical
lasso. The merging step is necessary as otherwise the network would
be dominated by (trivial) partial correlations between proteins and
their phosphorylated forms. We also created a mosaic plot compar-
ing the proposed clustering with the known cancer types (Fig. 3B,
see also Supplementary Fig. S3B for the corresponding cross-
tabulation of the sample numbers). Comparison between cluster
assignments and known cancer types shows an adjusted Rand index
of 0.73.
We further compared our approach to results reported in Hoadley
et al. (2014) obtained using a consensus clustering approach (COCA)
applied to six different TCGA data types (whole-exome DNA
sequencing, DNA copy-number variation, DNA methylation,
genome-wide mRNA gene expression, and RPPA protein expression
for 131 proteins). Supplementary Fig. S5 shows a comparison of the
MixGlasso clustering with COCA, as well as with the Pearson-Ward
clustering forming part of the input to COCA (PW-131), and the clus-
tering in Akbani et al. (2014) (PW-181). The comparison focuses on
2,809 TCGA samples in common across the analyses and a number of
differences are apparent. Interestingly, of the three clusterings that use
protein data only, MixGlasso most closely agrees with the integrative
consensus clustering (adjusted Rand Index 0.76, vs 0.65 for PW-131
and 0.6 for PW-181).
Insights from MixGlasso. The results below serve to illustrate
the nature of the output that can be immediately obtained from
MixGlasso. We note that further work will be needed to better
understand these results and to more comprehensively test the ro-
bustness of the reported patterns.
A pan-cancer, protein-defined cluster.
Cluster M spans 10/11 of the TCGA cancer types and there is no
clearly dominant cancer type. Cluster M has a distinct protein abun-
dance profile (Supplementary Fig. S4), with (among other proteins)
high abundance of Yap and Taz (which share the same target and
overlapping functions) and low levels of ATM, RBM15 and MTOR,
as well as low levels of some phospho-proteins (with the exception
of pp27 and pCHK2) which could be a signal of DNA damage and
cell cycle arrest.
A subset of ‘super basal’ breast cancers.
From n¼747 BRCA samples in our study, 70 are assigned to the clus-
ter that contains the majority of the OVCA samples (‘OVCA-like’),
rather than to the cluster that contains the majority of BRCA samples
(‘BRCA-like’). Most of these samples (67/70) belong to the basal sub-
type of breast cancer. Genomic similarities between basal and high-
grade serous ovarian samples have been previously noted (The Cancer
Genome Atlas Network, 2012). However, we find that only a subset
of basal breast samples (67 out of a total of 120 basal samples in the
study) appear in the OVCA-like cluster. We compared these samples
(‘basal-OVCA’) to the basal samples that remain clustered with
BRCA samples (‘basal-BRCA’; Fig. 4A, B). We find that in basal-
OVCA, a number of proteins show significantly different abundance
patterns that are typically associated with the basal subtype; this in-
cludes lower abundance of the three markers for ‘triple-negative’
breast cancer (ERa, PR and pHER2; total HER2 is lower among
basal-OVCA, but not significantly so), as well as higher abundance of
several cyclins, including CyclinE1 and CyclinB1, and higher activa-
tion of several PI3K pathway proteins, including total S6 and two
forms of p4EBP1 (Fig. 4B) as well as FoxM1. In each of these cases,
the characteristics that define the basal breast cancer subtype seem to
be amplified in the OVCA-basal samples.
4 Discussion and conclusions
Large datasets are often heterogeneous and often such data are in a
sense collections of smaller datasets with non-identical underlying
models. Furthermore, models capable of capturing even a very ap-
proximate view of molecular interplay tend to be relatively complex.
We think that these two factors mean that high-dimensional statis-
tical ideas will play a central role in the emerging areas of precision,
stratified and systems medicine, even when sample sizes become
much larger than is currently the case. The methods we described
Fig. 2.MixGlasso, simulation study. (A) Boxplot showing adjusted Rand index
of estimated cluster assignments compared to true cluster assignments, over
10 simulated datasets, each with total sample size n ¼ 3; 467. Data were gen-
erated from a Gaussian mixture model aiming to mimic characteristics of the
TCGA protein data (see SI for details). Inset boxplot displays the inferred
number of clusters using the Bayesian Information Criterion (BIC) and the
dashed horizontal line shows the true number of clusters in the simulation
(K¼9). (B) Boxplot showing adjusted Rand index (with respect to true cluster
assignments) over 10 simulated datasets with varying total sample size n
(number of clusters fixed to K¼9). See Main Text for a description of the dif-
ferent clustering methods. Note that the conventional Gaussian mixture
model can only be fitted for large sample sizes
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should be applicable to most continuous molecular data types and
can be run directly with minimal tuning.
We did not consider the case of truly large p in this paper. The
methods and ideas we discussed should be relevant to future work
aimed at that setting. At the same time, the challenges involved
should not be underestimated. As we showed, analyses involving
moderate numbers of variables but capturing patterns of interplay
are already challenging and require care.
Heterogeneity at one level of biology does not necessarily imply
heterogeneity at another. For example, differential expression may
or may not be accompanied by differences in patterns of interplay,
and differences in gene expression may or may not be accompanied
by changes in functional protein levels. Thus, although the intertu-
moral genomic heterogeneity of cancers is now well established, the
question of whether such heterogeneity appears also at the level of
signaling proteins has remained open. DiffNet applied to high-
quality protein data over thousands of patient samples supported
the notion that cancers differ at the protein network level.
Furthermore, we showed how MixGlasso could be used to reveal
new examples of commonalities across subtypes, where a subset of
samples from a certain type is closer to samples from a second type
than it is to other samples of the first type.
It is important to note that the graphical models in our analyses
are not causal models per se and links may be driven by non-causal
associations, e.g. co-regulation by an unobserved confounder (des-
pite this caveat, many high-scoring links in the networks ap-
peared consistent with the biochemical literature). However, our
approaches are rooted in a principled, likelihood-based framework
and it should be possible to extend the methods towards causal
models and interventional data.
Fig. 3. MixGlasso analysis of TCGA protein data. (A) Model selection using the Bayesian Information Criterion (BIC). (B) Mosaic plot of cluster membership in the
K ¼ 8 novel clusters with respect to the 11 TCGA cancer types. Dashed lines represent absent cancer types; column width is proportional to cluster-specific sample
size. (C) Cluster-specific networks. Strength of links is indicated by edge thickness, while color indicates cluster in which the link was observed; only relatively strong
links are shown. Nodes in white are related nodes that were highly correlated and merged prior to network analysis. The adjacent correlated (green) node was then
used for network generation. [Edges with partial correlations above 0.25 are shown]
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